Editorial: Entering the RNA Wonderland: Opportunities and Challenges for RNA Therapeutics in the Cardiovascular System

Editorial: Entering the RNA Wonderland: Opportunities and Challenges for RNA Therapeutics in the Cardiovascular System

Bibliographic Details
Main Authors:	Anna Zampetaki, Lars Maegdefessel
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-02-01
Series:	Frontiers in Physiology
Subjects:	non-coding RNA gene editing RNA structure cardiovascular diseases RNA therapeutics
Online Access:	https://www.frontiersin.org/article/10.3389/fphys.2020.00060/full

Similar Items

Long Non-coding RNA Structure and Function: Is There a Link?
by: Anna Zampetaki, et al.
Published: (2018-08-01)

Non-coding RNA therapeutics in cardiovascular diseases and risk factors: Systematic review
by: Meity Ardiana, et al.
Published: (2023-12-01)

RNA Biology Provides New Therapeutic Targets for Human Disease
by: Lorna W. Harries
Published: (2019-03-01)

Using RNAi in the treatment of cardiovascular diseases - therapeutics based on siRNA overview
by: Barbara Rusinowska
Published: (2022-08-01)

Current Advances in RNA Therapeutics for Human Diseases
by: Hannah Zogg, et al.
Published: (2022-03-01)

Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
by: De‐feng Li, et al.
Published: (2023-05-01)

Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases
by: Korina Karagianni, et al.
Published: (2024-03-01)

microRNA Therapeutics in Cancer — An Emerging Concept
by: Maitri Y. Shah, et al.
Published: (2016-10-01)

miRNA therapeutics in cardiovascular diseases: promises and problems
by: Nazila eNouraee, et al.
Published: (2015-06-01)

How mRNA therapeutics are entering the monoclonal antibody field
by: Lien Van Hoecke, et al.
Published: (2019-02-01)

Vaccine Formulation Strategies and Challenges Involved in RNA Delivery for Modulating Biomarkers of Cardiovascular Diseases: A Race from Laboratory to Market
by: Md. Adil Shaharyar, et al.
Published: (2023-01-01)

Evolutionary Patterns of Non-Coding RNA in Cardiovascular Biology
by: Shrey Gandhi, et al.
Published: (2019-01-01)

Editorial: RNA modifications and epitranscriptomics, Volume II
by: Kunqi Chen, et al.
Published: (2023-06-01)

Non-Coding RNA Editing in Cancer Pathogenesis
by: Giulia Romano, et al.
Published: (2020-07-01)

Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration
by: Minati eSingh
Published: (2013-01-01)

Editorial: RNA machines
by: Nikolay E. Shirokikh, et al.
Published: (2023-09-01)

Adenosine deaminase acting on RNA 1 (ADAR1) as crucial regulators in cardiovascular diseases: structures, pathogenesis, and potential therapeutic approach
by: Jieying Chen, et al.
Published: (2023-08-01)

Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration
by: Raj Kishore, et al.
Published: (2024-01-01)

Editorial: RNA plasticity: novel structures, shapes, modifications, and functions
by: Ulhas S. Kadam, et al.
Published: (2023-09-01)

RNA interference in practice /
by: 314123 Schepers, Ute
Published: (2005)

The Limitless Future of RNA Therapeutics
by: Tulsi Ram Damase, et al.
Published: (2021-03-01)

Editorial: RNA-chromatin interactions: Biology, mechanism, disease and therapeutics
by: Prabhu Mathiyalagan, et al.
Published: (2023-01-01)

Editorial: Plant RNA processing: discovery, mechanism and function
by: Lili Hao, et al.
Published: (2024-01-01)

Quality Control During Aminoacyl-tRNA Synthesis
by: Wang, S., et al.
Published: (2006-03-01)

The regulation of circRNA and lncRNAprotein binding in cardiovascular diseases: Emerging therapeutic targets
by: Huilei Zhao, et al.
Published: (2023-09-01)

RNA Therapeutics in Cardiovascular Precision Medicine
by: Ageliki Laina, et al.
Published: (2018-07-01)

Genomic Landscape and Potential Regulation of RNA Editing in Drug Resistance
by: Xu Zhou, et al.
Published: (2023-05-01)

Circular RNA as Therapeutic Targets in Atherosclerosis: Are We Running in Circles?
by: Jeffrey Triska, et al.
Published: (2023-07-01)

Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma—Progress and Challenges
by: Victor E. Nava, et al.
Published: (2022-02-01)

Editorial: Interplay between RNA-binding proteins and non-coding RNAs in tumor therapeutic resistance
by: Peixin Dong, et al.
Published: (2023-04-01)

Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
by: Sean C. Semple, et al.
Published: (2022-02-01)

Utilization and Potential of RNA-Based Therapies in Cardiovascular Disease
by: Emma Louise Robinson, MS, PhD, et al.
Published: (2022-09-01)

Mutual Correlation between Non-Coding RNA and S-Adenosylmethionine in Human Cancer: Roles and Therapeutic Opportunities
by: Laura Mosca, et al.
Published: (2021-06-01)

Dark Matter RNA: an Intelligent Scaffold for the Dynamic Regulation of the Nuclear Information Landscape
by: Georges eSt. Laurent, et al.
Published: (2012-04-01)

Identification of Long Non-Coding RNA Profiles and Potential Therapeutic Agents for Fibrolamellar Carcinoma Based on RNA-Sequencing Data
by: Janghyun Kim, et al.
Published: (2023-08-01)

Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges
by: Hara Kang, et al.
Published: (2023-10-01)

Editorial: RNA Biology in Cardiovascular Disease
by: Maarten M. G. van den Hoogenhof, et al.
Published: (2021-10-01)

Non-Coding RNA Databases in Cardiovascular Research
by: Deepak Balamurali, et al.
Published: (2020-09-01)

A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects
by: Heming Wang, et al.
Published: (2021-02-01)

De Novo A-to-I RNA Editing Discovery in lncRNA
by: Domenico Alessandro Silvestris, et al.
Published: (2020-10-01)